Wedge Capital Management L L P NC Has $800,000 Position in Envista Holdings Co. (NYSE:NVST)

Wedge Capital Management L L P NC lowered its stake in shares of Envista Holdings Co. (NYSE:NVST) by 24.6% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 46,356 shares of the company’s stock after selling 15,087 shares during the quarter. Wedge Capital Management L L P NC’s holdings in Envista were worth $800,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its stake in shares of Envista by 214.4% in the first quarter. UMB Bank n.a. now owns 2,094 shares of the company’s stock worth $36,000 after buying an additional 1,428 shares during the last quarter. Venturi Wealth Management LLC raised its holdings in Envista by 528.4% in the 4th quarter. Venturi Wealth Management LLC now owns 1,948 shares of the company’s stock worth $38,000 after acquiring an additional 1,638 shares during the period. Mitsubishi UFJ Trust & Banking Corp acquired a new position in Envista during the 4th quarter worth $86,000. Tower Research Capital LLC TRC lifted its position in Envista by 51.3% during the 4th quarter. Tower Research Capital LLC TRC now owns 11,057 shares of the company’s stock worth $213,000 after acquiring an additional 3,751 shares during the last quarter. Finally, Sterling Capital Management LLC boosted its holdings in Envista by 53.9% during the fourth quarter. Sterling Capital Management LLC now owns 11,105 shares of the company’s stock valued at $214,000 after acquiring an additional 3,888 shares during the period.

Analyst Ratings Changes

NVST has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. dropped their price objective on Envista from $20.00 to $19.00 and set a “neutral” rating on the stock in a research note on Thursday, March 6th. Morgan Stanley set a $16.00 target price on Envista in a report on Tuesday, April 15th. Piper Sandler dropped their price target on Envista from $18.00 to $17.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 30th. Robert W. Baird raised Envista from a “neutral” rating to an “outperform” rating and increased their price objective for the company from $21.00 to $23.00 in a research report on Tuesday, May 27th. Finally, Needham & Company LLC restated a “hold” rating on shares of Envista in a research note on Thursday, March 6th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $20.23.

Envista Stock Up 0.3%

Shares of NVST stock opened at $19.21 on Thursday. Envista Holdings Co. has a one year low of $14.22 and a one year high of $23.00. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.04 and a quick ratio of 1.76. The stock has a fifty day moving average price of $16.95 and a 200 day moving average price of $18.65. The stock has a market cap of $3.25 billion, a P/E ratio of -2.96, a price-to-earnings-growth ratio of 1.27 and a beta of 0.99.

Envista (NYSE:NVST) last issued its earnings results on Thursday, May 1st. The company reported $0.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.04. The business had revenue of $616.90 million during the quarter, compared to analysts’ expectations of $608.17 million. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. Envista’s quarterly revenue was down 1.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.26 EPS. Analysts predict that Envista Holdings Co. will post 1 earnings per share for the current year.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.